QQQ   267.51 (+0.24%)
AAPL   110.08 (+3.03%)
MSFT   202.54 (+1.07%)
FB   248.15 (-1.73%)
GOOGL   1,430.14 (-1.44%)
AMZN   2,960.47 (+0.19%)
NVDA   500.69 (+2.69%)
TSLA   449.39 (+1.64%)
BABA   273.82 (+0.52%)
CGC   15.74 (-3.79%)
GE   6.35 (-7.70%)
MU   49.15 (-3.13%)
AMD   77.94 (+4.02%)
T   28.63 (-1.04%)
F   6.87 (-4.98%)
ACB   6.32 (-3.22%)
GILD   64.21 (-1.29%)
NFLX   487.35 (+3.70%)
DIS   125.41 (-2.50%)
BAC   24.47 (-2.94%)
BA   156.35 (-2.97%)
QQQ   267.51 (+0.24%)
AAPL   110.08 (+3.03%)
MSFT   202.54 (+1.07%)
FB   248.15 (-1.73%)
GOOGL   1,430.14 (-1.44%)
AMZN   2,960.47 (+0.19%)
NVDA   500.69 (+2.69%)
TSLA   449.39 (+1.64%)
BABA   273.82 (+0.52%)
CGC   15.74 (-3.79%)
GE   6.35 (-7.70%)
MU   49.15 (-3.13%)
AMD   77.94 (+4.02%)
T   28.63 (-1.04%)
F   6.87 (-4.98%)
ACB   6.32 (-3.22%)
GILD   64.21 (-1.29%)
NFLX   487.35 (+3.70%)
DIS   125.41 (-2.50%)
BAC   24.47 (-2.94%)
BA   156.35 (-2.97%)
QQQ   267.51 (+0.24%)
AAPL   110.08 (+3.03%)
MSFT   202.54 (+1.07%)
FB   248.15 (-1.73%)
GOOGL   1,430.14 (-1.44%)
AMZN   2,960.47 (+0.19%)
NVDA   500.69 (+2.69%)
TSLA   449.39 (+1.64%)
BABA   273.82 (+0.52%)
CGC   15.74 (-3.79%)
GE   6.35 (-7.70%)
MU   49.15 (-3.13%)
AMD   77.94 (+4.02%)
T   28.63 (-1.04%)
F   6.87 (-4.98%)
ACB   6.32 (-3.22%)
GILD   64.21 (-1.29%)
NFLX   487.35 (+3.70%)
DIS   125.41 (-2.50%)
BAC   24.47 (-2.94%)
BA   156.35 (-2.97%)
QQQ   267.51 (+0.24%)
AAPL   110.08 (+3.03%)
MSFT   202.54 (+1.07%)
FB   248.15 (-1.73%)
GOOGL   1,430.14 (-1.44%)
AMZN   2,960.47 (+0.19%)
NVDA   500.69 (+2.69%)
TSLA   449.39 (+1.64%)
BABA   273.82 (+0.52%)
CGC   15.74 (-3.79%)
GE   6.35 (-7.70%)
MU   49.15 (-3.13%)
AMD   77.94 (+4.02%)
T   28.63 (-1.04%)
F   6.87 (-4.98%)
ACB   6.32 (-3.22%)
GILD   64.21 (-1.29%)
NFLX   487.35 (+3.70%)
DIS   125.41 (-2.50%)
BAC   24.47 (-2.94%)
BA   156.35 (-2.97%)
Log in
NASDAQ:TECH

BIO-TECHNE SEC Filings & 10K Form

$237.70
-6.20 (-2.54 %)
(As of 09/21/2020 12:00 AM ET)
Add
Compare
Today's Range
$235.75
Now: $237.70
$241.99
50-Day Range
$243.75
MA: $255.47
$278.87
52-Week Range
$155.17
Now: $237.70
$286.68
Volume155,496 shs
Average Volume220,422 shs
Market Capitalization$9.16 billion
P/E Ratio41.05
Dividend Yield0.52%
Beta0.98

SEC Filings

BIO-TECHNE (NASDAQ:TECH) SEC Filings

DateFilerForm TypeView
09/15/2020
4:02 PM
BIO-TECHNE (Filer)
Form DEFA14A
09/15/2020
4:00 PM
BIO-TECHNE (Filer)
Form DEF 14A
08/26/2020
3:36 PM
BIO-TECHNE (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
08/11/2020
5:22 PM
BIO-TECHNE (Issuer)
Furlow Brenda S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2020
5:21 PM
BIO-TECHNE (Issuer)
Eansor Norman David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2020
5:21 PM
BIO-TECHNE (Issuer)
Hippel James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/11/2020
5:20 PM
BIO-TECHNE (Issuer)
Kummeth Charles R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2020
6:07 PM
BIO-TECHNE (Issuer)
Kummeth Charles R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2020
5:58 PM
BIO-TECHNE (Issuer)
Kelderman Kim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2020
5:50 PM
BIO-TECHNE (Issuer)
Hippel James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2020
5:40 PM
BIO-TECHNE (Issuer)
Furlow Brenda S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/07/2020
5:33 PM
BIO-TECHNE (Issuer)
Eansor Norman David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2020
4:19 PM
BIO-TECHNE (Issuer)
Bushman Julie L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/05/2020
3:43 PM
BIO-TECHNE (Issuer)
Bushman Julie L (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
08/04/2020
5:30 AM
BIO-TECHNE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/08/2020
4:47 PM
BIO-TECHNE (Issuer)
Hippel James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/02/2020
4:13 PM
BIO-TECHNE (Issuer)
WIENS HAROLD J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2020
4:58 PM
BIO-TECHNE (Issuer)
Furlow Brenda S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/01/2020
4:58 PM
BIO-TECHNE (Issuer)
Eansor Norman David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2020
6:03 AM
BIO-TECHNE (Filer)
Form SD
Specialized Disclosure Report  
05/28/2020
4:41 PM
BIO-TECHNE (Issuer)
Kummeth Charles R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2020
4:13 PM
BIO-TECHNE (Issuer)
Eansor Norman David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/26/2020
4:13 PM
BAUMGARTNER ROBERT V (Reporting)
BIO-TECHNE (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
05/11/2020
5:35 AM
BIO-TECHNE (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/08/2020
3:17 PM
BIO-TECHNE (Issuer)
WIENS HAROLD J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2020
5:35 AM
BIO-TECHNE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
02/14/2020
3:13 PM
BIO-TECHNE (Issuer)
HIGGINS JOHN L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
02/04/2020
5:31 AM
BIO-TECHNE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
01/08/2020
3:34 PM
BIO-TECHNE (Issuer)
Kummeth Charles R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/27/2019
3:31 PM
BIO-TECHNE (Issuer)
Kummeth Charles R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2019
3:32 PM
BIO-TECHNE (Issuer)
Kummeth Charles R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/23/2019
3:31 PM
BIO-TECHNE (Issuer)
Kummeth Charles R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/17/2019
3:32 PM
BIO-TECHNE (Issuer)
Furlow Brenda S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/12/2019
3:35 PM
BIO-TECHNE (Issuer)
Kummeth Charles R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/06/2019
3:50 PM
BIO-TECHNE (Issuer)
WIENS HAROLD J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
12/02/2019
3:22 PM
BIO-TECHNE (Issuer)
Kummeth Charles R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/29/2019
10:35 AM
BIO-TECHNE (Issuer)
Nusse Roeland (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/25/2019
3:25 PM
BIO-TECHNE (Issuer)
Hippel James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
11/06/2019
3:41 PM
BIO-TECHNE (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
11/06/2019
3:32 PM
BIO-TECHNE (Filer)
Form 10-K/A
10/29/2019
5:33 AM
BIO-TECHNE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/28/2019
4:06 PM
BIO-TECHNE (Issuer)
KEEGAN JOSEPH D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2019
4:05 PM
BIO-TECHNE (Issuer)
WIENS HAROLD J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2019
4:04 PM
BIO-TECHNE (Issuer)
VESSEY RUPERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2019
4:00 PM
BIO-TECHNE (Issuer)
STEER RANDOLPH C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2019
4:00 PM
BIO-TECHNE (Issuer)
Nusse Roeland (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2019
3:59 PM
BIO-TECHNE (Issuer)
Seth Alpna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2019
3:59 PM
BIO-TECHNE (Issuer)
HIGGINS JOHN L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/28/2019
3:58 PM
BAUMGARTNER ROBERT V (Reporting)
BIO-TECHNE (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/09/2019
5:31 AM
BIO-TECHNE (Filer)
Form 10-K/A
09/11/2019
3:42 PM
BIO-TECHNE (Issuer)
Kummeth Charles R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
09/09/2019
3:30 PM
BIO-TECHNE (Filer)
Form DEFA14A
09/09/2019
3:30 PM
BIO-TECHNE (Filer)
Form DEF 14A
08/28/2019
3:16 PM
BIO-TECHNE (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
08/21/2019
3:34 PM
BIO-TECHNE (Issuer)
Eansor Norman David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2019
3:33 PM
BIO-TECHNE (Issuer)
Hippel James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2019
3:33 PM
BIO-TECHNE (Issuer)
Kummeth Charles R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/21/2019
3:32 PM
BIO-TECHNE (Issuer)
Furlow Brenda S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/15/2019
3:45 PM
BIO-TECHNE (Issuer)
Kummeth Charles R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2019
3:11 PM
BIO-TECHNE (Issuer)
Eansor Norman David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2019
3:10 PM
BIO-TECHNE (Issuer)
Kelderman Kim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/09/2019
3:10 PM
BIO-TECHNE (Issuer)
Kummeth Charles R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/06/2019
5:32 AM
BIO-TECHNE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
07/12/2019
3:18 PM
BIO-TECHNE (Issuer)
Kummeth Charles R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/10/2019
3:46 PM
BIO-TECHNE (Issuer)
Kummeth Charles R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2019
4:49 PM
BIO-TECHNE (Issuer)
VESSEY RUPERT (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
07/02/2019
4:45 PM
BIO-TECHNE (Issuer)
VESSEY RUPERT (Reporting)
Form 3
Initial statement of beneficial ownership of securities  
06/25/2019
3:32 PM
BIO-TECHNE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
06/14/2019
3:13 PM
BIO-TECHNE (Issuer)
Eansor Norman David (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
06/06/2019
3:30 PM
BIO-TECHNE (Issuer)
HIGGINS JOHN L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2019
3:29 PM
BIO-TECHNE (Issuer)
Furlow Brenda S. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
05/29/2019
7:31 AM
BIO-TECHNE (Filer)
Form SD
Specialized Disclosure Report  
05/07/2019
5:32 AM
BIO-TECHNE (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
05/02/2019
3:14 PM
BIO-TECHNE (Issuer)
Hippel James (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
04/30/2019
5:32 AM
BIO-TECHNE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
04/15/2019
4:00 PM
BIO-TECHNE (Filed by)
ChemoCentryx, Inc. (Subject)
Form SC 13G/A
02/14/2019
9:08 AM
BIO-TECHNE (Subject)
BROWN CAPITAL MANAGEMENT LLC (Filed by)
Form SC 13G/A
02/11/2019
10:49 AM
BIO-TECHNE (Subject)
VANGUARD GROUP INC (Filed by)
Form SC 13G/A
02/07/2019
3:32 PM
BIO-TECHNE (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
02/05/2019
5:30 AM
BIO-TECHNE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
11/07/2018
7:17 AM
BIO-TECHNE (Filer)
Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans  
11/07/2018
7:03 AM
BIO-TECHNE (Filer)
Form 10-Q
General form for quarterly reports under Section 13 or 15(d)  
10/30/2018
5:55 AM
BIO-TECHNE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
10/29/2018
4:09 PM
BIO-TECHNE (Issuer)
STEER RANDOLPH C (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2018
4:07 PM
BIO-TECHNE (Issuer)
Seth Alpna (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2018
4:02 PM
BIO-TECHNE (Issuer)
WIENS HAROLD J (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2018
4:00 PM
BIO-TECHNE (Issuer)
Nusse Roeland (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2018
3:57 PM
BIO-TECHNE (Issuer)
KEEGAN JOSEPH D (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2018
3:54 PM
BIO-TECHNE (Issuer)
HIGGINS JOHN L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
10/29/2018
3:51 PM
BAUMGARTNER ROBERT V (Reporting)
BIO-TECHNE (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
10/26/2018
3:09 PM
BIO-TECHNE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
09/11/2018
3:31 PM
BIO-TECHNE (Filer)
Form DEFA14A
09/11/2018
3:30 PM
BIO-TECHNE (Filer)
Form DEF 14A
09/05/2018
4:00 PM
BIO-TECHNE (Filer)
Form 8-K
Current report pursuant to Section 13 or 15(d)  
08/31/2018
3:39 PM
BIO-TECHNE (Issuer)
Kummeth Charles R. (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/28/2018
4:30 PM
BAUMGARTNER ROBERT V (Reporting)
BIO-TECHNE (Issuer)
Form 4
Statement of changes in beneficial ownership of securities  
08/27/2018
3:47 PM
BIO-TECHNE (Filer)
Form 10-K
Annual report pursuant to Section 13 or 15(d)  
08/27/2018
3:12 PM
BIO-TECHNE (Issuer)
HIGGINS JOHN L (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2018
3:28 PM
BIO-TECHNE (Issuer)
Kelderman Kim (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
08/10/2018
3:18 PM
BIO-TECHNE (Issuer)
Dinarello Charles A (Reporting)
Form 4
Statement of changes in beneficial ownership of securities  
This page was last updated on 9/21/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.